1du Buf-Vereijken PW,Branten AJ,Wetzels JF.Idiopathic membranous nephropathy:outline and rationale of a treatment strategy.Am J Kidney Dis,2005,46(6):1012-1029.
2Ponticelli C,Zucchelli P,Passerini P,et al.A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.Kidney Int,1995,48 (5):1600-1604.
3Schieppati A,Perna A,Zamora J,et al.Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.Cochrane Database Syst Rev,2004,18(4):CD004293.
4Troyanov S,Wall CA,Miller JA,et al.Idiopathic membranous nephropathy:definition and relevance of a partial remission.Kidney Int,2004,66(3):1199-1205.
5Hogan SL,Muller KE,Jennette JC,et al.A review of therapeutic studies of idiopathic membranous glomerulopathy.Am J Kidney Dis,1995,25(6):862-875.
6Ponticelli C,Altieri P,Scolari F,et al.A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.J Am Soc Nephrol,1998,9(3):444-450.
7Passerini P,Ponticelli C.Corticosteroids,cyclophosphamide,and chlorambucil therapy of membranous nephropathy.Semin Nephrol,2003,23 (4):355-361.
8Ahuja M,Goumenos D,Shortland JR,et al.Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy? Am J Kidney Dis,1999,34(3):521-529.
9Cattran DC,Greenwood C,Ritchie S,et al.A controlled trial of cyclosporine in patients with progressive membranous nephropathy.Canadian Glomerulonephritis Study Group.Kidney Int,1995,47(4):1130-1135.
10Cattran DC,Appel GB,Hebert LA,et al.Cyclosporine in patients with steroid-resistant membranous nephropathy:a randomized trial.Kidney Int,2001,59(4):1484-1490.
二级参考文献15
1Folk R J, Jennette JC, Nachman PH.Membranous glomerulopathy. In: Brenner BM, ed. Brenner & Rector's The Kidney.6th ed. Philadelphia: W B Saunders,1999. 1284-1292.
2Ponticelli C, Passerini P. Membranous glomerulonephritis. In: Massry SG, Glassock RJ, eds. Massry & Glassock's Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. 707-713.
3Muirhead N. Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int, 1999, S70:S47-S55.
4Kida H, Asamoto T, Yokoyama H, et al.Long-term prognosis of idiopathic membranous nephropathy. Clin Nephrol, 1986,25: 64-69.
5Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int, 1995, 48: 1600-1604.
6Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol, 1998, 9: 444-450.
7Ahuja M, Goumenos D, Shortland JR, et al.Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy? Am J Kidney Dis, 1999, 34: 521-529.
9Fritsche L, Budde K, Farber L, et al.Treatment of membranous glomerulopathy with cyclosporine A: How much patience is required? Nephrol Dial Transplant, 1999,14: 1036-1037.
10Miller G, Zimmerman R, Radhakrishnan J,et al. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis, 2000, 36: 250-256.
